#USA #Tempe #Clinical Research #Panoramic Health #Cathy Collins

Panoramic Health Welcomes Cathy Collins to Board of Directors

Panoramic Health, a preeminent provider in integrated kidney care, has officially welcomed Cathy Collins to its Board of Directors. This strategic appointment aims to enhance their clinical research initiatives through Panoramic Science, particularly in the area of cardiovascular, renal, and metabolic (CVRM) therapeutic research. The decision underscores their commitment to advancing high-quality clinical research that meets the growing sponsor demand for reliable and scalable research sites.

The Expertise of Cathy Collins

With over 30 years in clinical research, Collins brings a wealth of experience to the organization. Her career is marked by significant leadership roles, including Chief Executive Officer of various research organizations and board memberships. This background equips her with comprehensive insights into site operations and strategy development essential for the advancement of clinical research.

Before joining Panoramic Health, Collins played pivotal roles at Headlands Research, where her strategic leadership contributed to remarkable growth. Her responsibilities included serving as Senior Vice President of Site Strategy and Interim CEO, ultimately leading the company to a successful exit for its private equity partners in 2025. Her extensive track record showcases her proficiency in enhancing site performance and scalability in clinical research.

Panoramic Science's Role

Panoramic Science operates over 20 research sites throughout the United States, focusing on studies concerning nephrology and chronic kidney disease, while also expanding into cardiovascular and metabolic research areas, including diabetes and obesity. The integrated site network allows independent nephrologists to participate actively in clinical research, staying at the forefront of relevant advancements in their specialty fields.

Lisa Kiehne, the President of Panoramic Science, emphasized how Collins’ operational depth and board-level experience will significantly benefit the organization as they extend their research capabilities beyond chronic kidney disease. Her guidance will be instrumental in delivering high-quality trials while meeting the evolving needs of their sponsors.

Future Outlook

Collins expressed her enthusiasm for joining Panoramic Health, noting the organization's strategic position at the confluence of specialty care and clinical research. She highlighted the importance of Panoramic Science’s expanding footprint and engaged physician partners, projecting a strong foundation for delivering substantial value to both sponsors and patients.

Adam Abramson, a Partner at Audax Private Equity, reflected on the value Collins brings, asserting that her extensive background will help solidify Panoramic Science’s role as a leader in the clinical research sphere, particularly in the CVRM domain.

In addition to its Board of Directors, Panoramic Health benefits from its Scientific Advisory Board comprising renowned experts in nephrology. This board significantly influences the research strategy, fostering innovative improvements in patient care.

For those interested in further details about Panoramic Science, its national research capabilities, and its commitment to advancing clinical research, visiting panoramichealth.com/science is recommended. To learn more about Panoramic Health's mission and services, one can explore panoramichealth.com.

About Panoramic Health

Panoramic Health is a leading provider dedicated to integrated kidney care, aligned with nephrology practices across the United States and serving hundreds of thousands of patients. Their mission focuses on slowing disease progression and enhancing life quality by providing nephrologists with cutting-edge clinical and operational solutions. As a company founded by nephrologists, it prioritizes clinical autonomy while reducing administrative burdens, ultimately improving care quality and enabling sustainable growth opportunities within the scope of complex kidney patient care.

About Audax Private Equity

Audax Private Equity, based in Boston and with operations across key global cities, specializes in investments across the North American middle market. Their strategic focus on value creation is evident in their extensive portfolio, which has seen investments in more than 180 platforms and over 1,400 add-on acquisitions since its inception in 1999.

By contextualizing its growth and evolution, Panoramic Health reflects a genuine commitment towards advancing healthcare solutions in collaboration with dedicated leaders like Cathy Collins.